U.S. Hearing Loss Disease Treatment Market Size & Outlook
U.S. hearing loss disease treatment market, 2018-2030 (US$M)
Related Markets
U.S. hearing loss disease treatment market highlights
- The U.S. hearing loss disease treatment market generated a revenue of USD 3,637.3 million in 2023 and is expected to reach USD 5,074.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, devices was the largest revenue generating product in 2023.
- Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Hearing loss disease treatment market data book summary
| Market revenue in 2023 | USD 3,637.3 million |
| Market revenue in 2030 | USD 5,074.1 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Devices |
| Fastest growing segment | Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Devices, Drugs |
| Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.8% of the global hearing loss disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. hearing loss disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 663.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hearing Loss Disease Treatment Market Scope
Hearing Loss Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. hearing loss disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.89% in 2023. Horizon Databook has segmented the U.S. hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in prevalence of hearing abnormalities in the U.S. is leading to launch of new products with advanced technologies. For instance, in December 2022, Sony Electronics announced the launch of its very first Over-the-Counter (OTC) hearing aids in the U.S. market.
The company developed and introduced these advanced hearing aids in collaboration with WS Audiology (WSA). Moreover, companies are focusing on developing new drugs to address hearing loss in the U.S.
For instance, in December 2022, Frequency Therapeutics, Inc., the U.S.-based clinical-stage regenerative medicine, announced initiation of clinical trials for its newly developed drug on Sensorineural Hearing Loss (SNHL), FX-345.
Reasons to subscribe to U.S. hearing loss disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. hearing loss disease treatment market databook
-
Our clientele includes a mix of hearing loss disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into U.S. hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. hearing loss disease treatment market report size, by product, 2018-2030 (US$M)
U.S. Hearing Loss Disease Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
